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Abstract
Objective—Because evidence-based psychotherapies of 12 to 20 sessions can be perceived as
too lengthy and time intensive for the treatment of depression in primary care, a number of studies
have examined abbreviated psychotherapy protocols. The purpose of this study was to conduct a
systematic review and meta-analysis to determine the efficacy of brief psychotherapy (i.e., ≤ 8
sessions) for depression.
Methods—We used combined literature searches in PubMed, EMBASE, PsycINFO, and an
Internet-accessible database of clinical trials of psychotherapy to conduct two systematic searches:
one for existing systematic reviews and another for randomized controlled trials (RCTs). Included
studies examined evidence-based psychotherapy(s) of 8 or fewer sessions, focused on adults with
depression, contained an acceptable control condition, were published in English, and used
validated measures of depressive symptoms.
Results—We retained 2 systematic reviews and 15 RCTs evaluating cognitive behavioral
therapy, problem-solving therapy, and mindfulness-based cognitive therapy. The systematic
reviews found brief psychotherapies to be more efficacious than control, with effect sizes ranging
from −0.33 to −0.25. Our meta-analysis found six to eight sessions of cognitive behavioral therapy
to be more efficacious than control (ES −0.42, 95% CI −0.74 to −0.10, I2=56%). A sensitivity
analysis controlled for statistical heterogeneity but showed smaller treatment effects (ES −0.24,
95% CI −0.42 to −0.06, I2=0%).
Conclusions—Depression can be efficaciously treated with six to eight sessions of
psychotherapy, particularly cognitive behavioral therapy and problem-solving therapy. Access to
non-pharmacologic treatments for depression could be improved by training health care providers
to deliver brief psychotherapies.
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Depressive disorders present a major public health concern. The prevalence of current
depression among U.S. adults is 6.6% [1], with a lifetime prevalence rate of 16 to 18% [2].
Particularly high rates have been found in primary care settings [3] where a high proportion
of patients with depressive disorders are treated [4]. Medication is by far the most
commonly utilized intervention in primary care settings [5, 6], despite extensive evidence
and clinical guidelines suggesting that efficacious treatments for depression include both
pharmacotherapy and psychotherapy [7].
In recent years, there has been a growing interest in and commitment to the integration of
psychotherapy and other mental health services into primary care settings [8]. Providing
primary care patients with the option of receiving psychotherapy for depression is an
important objective for multiple reasons: there are many patients who prefer psychotherapy
to medication [9]; there is a need to provide alternative treatments for patients who do not
improve on or cannot tolerate antidepressant medication [10]; and there may be unique
benefits from psychotherapy in terms of costs and relapse prevention [11].
Perhaps the most significant barrier to providing psychotherapies in primary care settings is
that many empirically supported psychotherapy treatment protocols consist of at least 12 to
20 weekly 1-hour sessions [12, 13]. While this treatment duration is much abbreviated
compared with older approaches to the provision of psychotherapy [14], it is arguably still
too intensive for reliable implementation in primary care settings [15].
Recognizing that time and resource constraints present important barriers to effectively
implementing standard-duration psychotherapies (i.e., 12 to 20 sessions) for depression in
primary care settings, this review evaluates whether psychotherapy for depression can be
efficacious after a period of 8 or fewer sessions. Eight sessions is roughly half the length of
standard-duration psychotherapies, and this treatment duration has been used in previous
research examining standard-duration vs. brief psychotherapy [16]. The present review
aimed to evaluate the evidence on brief psychotherapy for depression by employing a
complex systematic review methodology [17], with particular attention devoted to the
training received by providers delivering brief psychotherapies and the reporting of clinical
outcomes beyond depression severity.
METHODS
We utilized a combined approach for conducting a complex systematic review [17],
identifying and evaluating existing systematic reviews and supplementing these reviews by
searching for and evaluating original research not included in these reviews.
SEARCH STRATEGY
We developed search strategies in consultation with a master librarian and conducted
searches in three stages. First, we searched MEDLINE (via PubMed), Embase, and
PsycINFO for relevant, good-quality, English-language systematic reviews that were
published within the past 10 years (January 1, 2000 – May 2010). Second, we used a well-
documented Internet-accessible database of psychotherapy trials that was current through
January 2010 [18]. We used this database of 243 trials as a data source for original research,
searching for studies coded as including adults with a mood disorder who received face-to-
face psychotherapy at a dose of eight or fewer therapy sessions. Finally, we searched for
publications in MEDLINE (via PubMed), PsycINFO, and Embase from January 2009 (one
year prior to the search date of the online database) through August 1, 2010 to complement
the Internet-accessible database of psychotherapy trials. We supplemented electronic
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searching by examining the bibliographies of included studies and review articles. The full
search strategies are available upon request from the authors.
STUDY SELECTION
Using prespecified inclusion/exclusion criteria, pairs of trained researchers (either PhD or
MD) reviewed the list of titles and abstracts, then selected articles identified from any of the
computerized and manual searches described above for further review of the full text. Each
article retrieved was reviewed using a brief screening form. To be included in our study,
systematic reviews had to be rated as good-quality using quality criteria adapted from a
previous review [19], and original research studies had to be an RCT, compare an eligible
psychotherapy of eight or fewer sessions to control, and report effects on depressive
symptoms. Detailed eligibility criteria are described in Table 1.
DATA EXTRACTION AND QUALITY ASSESSMENT
For systematic reviews, we assessed the comprehensiveness of the search strategy, the
description and appropriateness of inclusion criteria, whether primary studies were assessed
for quality and the adequacy of the quality measure, the reproducibility of methods to assess
studies, whether the results of relevant studies were combined appropriately, whether
heterogeneity and publication bias were assessed, and whether the conclusions were
supported by the data presented. Systematic reviews were rated “good” if the conclusions
were supported by the data presented and there were no important study limitations.
For newly identified original research studies, trained researchers abstracted data in
duplicate from published reports into evidence tables. For eligible trials previously included
in the two systematic reviews, we abstracted summary data from the reviews and
supplemented these data by using the original publications when the reviews had incomplete
information. We assessed risk of bias using the key quality criteria described in the Agency
for Healthcare Research and Quality (AHRQ) Methods Guide for Effectiveness and
Comparative Effectiveness Reviews [20], adapted for this specific topic. We abstracted data
on adequacy of randomization and allocation concealment, comparability of groups at
baseline, blinding, completeness of followup and differential loss to followup, whether
incomplete data were addressed appropriately, validity of outcome measures, and conflict of
interest. Using these data elements, we assigned a summary quality score of “good,” “fair,”
or “poor” to individual RCTs.
DATA SYNTHESIS AND ANALYSIS
When good-quality systematic reviews were identified, we summarized the reviews’
findings in narrative form. For original research studies, we critically analyzed their
characteristics, methods, and findings, and then used published guidelines to evaluate
whether the new evidence was likely to change estimates from prior reviews [20]. If so, we
updated prior meta-analyses.
Because studies did not use a single common instrument to measure depression severity, our
meta-analysis calculated effect sizes for each study by subtracting (at posttest) the average
score of the control group from the average score of the experimental group and dividing the
result by the pooled standard deviations (SDs) of the experimental and control groups. We
then converted these estimates to the number needed to treat (NNT) using the approach
described by Kraemer [21]. When studies used more than one validated instrument to assess
depression severity, we used the mean of the effect sizes so that each study (or control
group) contributed only one effect size. When means and SDs were not reported, we used
other statistics (e.g., event rates) to calculate the effect size. For studies with more than one
active eligible psychotherapeutic intervention (e.g., behavioral therapy and cognitive therapy
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arms) compared to a single control, we combined the intervention arms to avoid lack of
independence that would be created if we entered each intervention into the analysis
separately [22].
We assessed for heterogeneity in outcomes between studies using the Q statistic and the I2
statistic [23]. Publication bias was tested by inspecting the funnel plot of the meta-analysis.
We conducted preplanned subgroup analyses by study quality and type of control group;
there was not sufficient variability or numbers of studies to conduct other subgroup
analyses. We used an influence analysis, which drops one study at a time and recomputes
the treatment effect, to determine the influence of individual studies on the overall effect.
We used the computer program Comprehensive Meta-analysis, Version 2.2.021 (www.meta-
analysis.com/pages/about_us.html), to conduct all meta-analyses. Finally, we assigned
strength of evidence ratings for the different brief psychotherapies using principles from the




Systematic Reviews—Using the combined literature search of PubMed, Embase, and
PsycINFO, we identified references for 560 potential systematic reviews (Figure 1). Two
eligible reviews were retained: Cuijpers and colleagues [25] and Cape and colleagues [26].
Neither review focused exclusively on brief psychotherapy for depression. Cuijpers
completed a good-quality meta-analysis of 15 studies that examined psychotherapies for
depression in primary care; a sub-analysis was completed on the studies of psychotherapies
with 6 or fewer sessions (k=7). Cape completed a good-quality meta-analysis and meta-
regression of 34 studies examining the effectiveness of psychotherapies for various mental
health problems that consisted of fewer than 10 sessions; sub-analyses were completed on
the studies of cognitive behavioral therapy (CBT; k=4), problem-solving therapy (PST;
k=5), and counseling (k=4) specifically for depression.
Primary Literature—Using the combined searches for primary literature in electronic
databases (MEDLINE, Embase, and PsycINFO), in a well-documented Internet-accessible
database of psychotherapy trials [18], and in bibliographies of included studies, we
identified 866 citations (Figure 2). We retained 20 articles representing 15 unique studies.
Only 8 of these 15 studies had been previously reviewed in either the Cuijpers [25] or Cape
[26] reviews. Study characteristics from the 15 relevant RCTs of brief psychotherapy are
summarized in Table 2. For quality assessments, studies rated as fair or poor were often
rated as such due to inadequately addressing incomplete outcome data and not having
outcome assessors who were blind to treatment assignment. Characteristics of
psychotherapy interventions used in the 15 RCTs of brief psychotherapy are summarized in
Table 3. Data were infrequently reported on quality of life, social functioning, occupational
status, patient satisfaction, and adverse treatment effects (Table 4).
EFFICACY OF BRIEF PSYCHOTHERAPY
Systematic Reviews—In the Cuijpers’ systematic review [25], the sub-analysis
examining psychotherapies with six or fewer sessions (k=5 PST and 2 CBT) found these
treatments to have a small but significant positive effect for the treatment of depression in
primary care (ES −0.25, 95% CI −0.48 to −0.02, NNT=7.14). This effect size was not
significantly different from that for psychotherapies of 7 to 16 sessions (ES −0.36, 95% CI
−0.54 to −0.17). In Cape’s review [26], the sub-analyses on psychotherapies for depression
with 10 or fewer sessions demonstrated a significant but small effect favoring brief CBT
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over usual general practitioner care for depression (k=4; ES −0.33, 95% CI −0.60 to −0.06)
and positive but statistically nonsignificant effects for PST (k=5; ES −0.26, 95% CI −0.49 to
0.03) and counseling (k=4; ES −0.41, 95% CI −0.84 to 0.03) over usual general practitioner
care. No significant differences in efficacy were found between CBT, PST, and counseling.
Primary Literature—While six of the eight identified PST studies were previously
included in the systematic reviews, the prior reviews only included two of the six CBT
studies that we identified. Because the 4 newly identified studies of CBT contained 535 of
the total 713 participants across the 6 CBT studies, we conducted an updated and more
adequately powered meta-analysis of brief CBT (6 to 8 sessions) for depression.
In the meta-analysis, we found that participants receiving brief CBT for depression were
more likely than participants receiving a control treatment to have reduced symptoms of
depression (ES −0.42, 95% CI −0.74 to −0.10), but treatment effects differed significantly
across studies (Cochran Q=13.74, p=0.03, I2=56%) (Figure 3). The ES of −0.42 corresponds
to an NNT of approximately 4.5. A funnel plot did not suggest significant publication bias,
but with only six studies, this method has limited power to detect publication bias. In an
influence analysis conducted to examine the moderate level of variability present, the
summary estimate ranged from −0.24 to −0.53, with the trial by Wilson [27] having the
greatest influence. This trial was the only CBT study to use a waitlist control condition as
the comparator. Based on a priori hypotheses of variables that might influence the effect size
estimate, we conducted two sensitivity analyses. In the first, we removed the single poor-
quality study [28] and found that brief CBT for depression continued to be significantly
more effective than control (ES −0.50, 95% CI −0.91 to −0.09), but treatment effects
remained significantly heterogeneous (Cochran Q=13.71, p=0.008, I2=71%). In the second,
we removed the poor-quality [28] study and the study with a waitlist comparator [27] and
found that treatment effects of brief CBT for depression were smaller (ES −0.24, 95% CI
−0.42 to −0.06) but homogeneous (Cochran Q=1.44, p=0.70, I2=0%). This effect size
corresponds to an NNT of approximately 8.
Since only 92 of the total 973 participants across the 8 PST studies were from the 2 newly
identified studies of PST, we did not conduct an updated meta-analysis for PST. The single
study of MBCT identified in our review found 8 sessions of MBCT to be more efficacious
than treatment as usual at reducing depressive symptoms at 8 weeks (F=13.42, p=0.001)
[29].
NON-MENTAL HEALTH TREATMENT PROVIDERS
In all four trials that involved non-mental health professionals (e.g., nurses, allied health
professionals, and general practitioners) as treatment providers, the intervention was PST.
Compared to the PST trials that used solely mental health professionals, the trials involving
non-mental health professionals did not have a pattern of results suggesting any meaningful
differences in efficacy for PST. Quantitative syntheses to examine differences on the basis
of provider type, treatment intensity, individual versus group, or telephone versus in-person
could not be completed because there was not an adequate number of studies in each of
these subgroups.
DISCUSSION
We identified 2 systematic reviews and 15 randomized controlled trials of brief
psychotherapy (i.e., ≤ 8 sessions) for depression, encompassing 1716 patients with MDD or
depressive symptomatology. Both systematic reviews concluded that brief CBT and PST are
efficacious for the acute-phase treatment of depression in primary care. This conclusion was
corroborated by our analyses of 15 randomized controlled trials, 7 of which had not been
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included in either of the two identified systematic reviews. Effect sizes for brief
psychotherapy are modest but at present appear comparable to those observed in trials of
antidepressant medications and of standard duration psychotherapies [30]. Table 5
summarizes the strength of evidence.
Our review found that brief psychotherapies have been provided by psychologists, graduate
students, nurses, general practitioners, and other allied health professionals who had
received training and supervision specific to the intervention being conducted. Details about
training were sparse, meaning that the degree of training necessary to replicate studies’
results is uncertain. A key component of replicating positive treatment effects may be
fidelity monitoring, which is likely to be particularly important with generalist clinicians.
This review aimed to determine the overall efficacy of brief psychotherapies rather than the
comparative effectiveness of brief vs. standard-duration psychotherapies. However,
Cuijpers’ review [25] found no statistically significant differences between psychotherapies
delivered in 6 sessions compared to psychotherapies delivered in 7 to 16 sessions.
Additionally, in an important trial conducted by Shapiro and colleagues [16], 117 patients
with depression were randomized to either 8 or 16 sessions of manualized psychotherapy,
and 16 sessions was found to be superior to 8 only for those with severe depression. This
trial did not meet our inclusion criteria due to the comparator condition being an active
psychotherapy, but the findings are consistent with those from the present review and the
trial design merits imitation by other researchers.
The present study has a number of strengths, including a protocol-driven review, a
comprehensive search, careful quality assessment, and rigorous quantitative synthesis
methods. Additionally, this is the first review to our knowledge to focus exclusively on brief
psychotherapy for depression. However, the existing literature leaves multiple unresolved
questions. First, the question of whether brief psychotherapies are less efficacious than
standard-duration psychotherapies (i.e., 12 to 20 sessions) needs to be more fully answered
in the context of controlled trials. Second, too few studies assessed long-term outcomes after
the conclusion of brief psychotherapies (e.g., 6 months or longer) or included a broad set of
outcome measures (e.g., quality of life, social functioning, and occupational status). Third, it
remains to be determined which brief psychotherapies (CBT, PST, or other) can be provided
with high treatment fidelity by different professionals, such as nurses, nurse practitioners,
primary care physicians, social workers, or clinical chaplains. Fourth, the studies included in
this review were composed primarily of Caucasian, middle-aged females, limiting
applicability to many other segments of society. Finally, the relatively few studies included
in this review did not allow for stratified comparisons on important variables such as
depression severity (i.e., mild, moderate, severe), treatment setting (e.g., mental health
clinic, primary care), or augmentation of brief psychotherapy with medication.
CONCLUSIONS
Brief psychotherapy is an effective option for the acute-phase treatment of depression. With
many protocols requiring only 6 sessions of 30 minutes each that can be provided by either
mental health professionals or trained non-mental health providers, brief psychotherapies
present an attractive treatment alternative for implementation in the primary care
environment. Although future research is plainly needed, immediate attention is demanded
by the enormous human suffering and high economic burden associated with depressive
disorders.
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Figure 1. Results of literature search for systematic reviews
Systematic review search: (“depressive symptoms” or “depression [Mesh]” or “depressive
disorder [Mesh]” or “depression” or (“minor” and “depression”) or (“subthreshold” and
“depression”) or (“subsyndromal” and “depression”) or “major depressive disorder [Mesh]”
or “dysthymia” or “dysthymic disorder [Mesh]” or “adjustment disorder [Mesh]”) and
(“cognitive behavioral therapy” or “CBT” or “cognitive therapy” or “behavior therapy” or
“interpersonal therapy” or “IPT” or “problem-solving therapy” or “PST” or “mindfulness-
based cognitive therapy” or “MBCT” or (“cognitive behavioral analysis system” and
“therapy”) or “CBASP” or “dialectical behavioral therapy” or “DBT” or “functional analytic
psychotherapy” or “FAP” or (“acceptance” and “commitment” and “therapy”) or “ACT” or
“short-term psychodynamic therapy” or “psychotherapy, brief [Mesh]”) and (“Cochrane
Database Syst Rev [TA]” or “search [Title/Abstract]” or “meta-analysis [Publication type]”
or “MEDLINE [Title/Abstract] or (“systematic [Title/Abstract]” and “review [Title/
Abstract]”)). Limits: English, adults 19+ years, publication date from 2000.
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Figure 2. Results of literature search for RCTs
RCT search: ((RCTs coded in Cuijpers (2008) internet database (http://
www.psychotherapyrcts.org/index.php?id=3) as “Nsessions ≤ 8” and “Targetgruop = 1 or 2
or 3 or 6” and “FormGSH = 0”) or (“Interpersonal therapy” or “problem-solving therapy” or
“mindfulness-based cognitive therapy” or “cognitive behavioral analysis system of
psychotherapy” or “dialectical behavior therapy” or “functional analytic psychotherapy” or
“acceptance and commitment therapy”)) and (“depressive disorder [Mesh]” or (“depressive”
and “disorder”) or “depressive disorder” or “depression” or “depression [Mesh]” or
“depressive”). Limits: English, human, adults 19+ years, randomized controlled trial,
publication date from January 1, 2009 to July 31, 2010.
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Meta-analysis of Brief CBT for Depression
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Table 1
Summary of Inclusion and Exclusion Criteria
Study characteristic Inclusion criteria Exclusion criteria
Study design Randomized controlled trial None
Population Adults with major depressive disorder (MDD), dysthymic disorder, or
subthreshold (minor) depression in acute-phase treatment
Treatment-resistant depression, postpartum
depression, premenstrual dysphoric
disorder, bipolar disorder, seasonal affective
disorder, or double depression (i.e., MDD
and dysthymia)
Interventionsa Cognitive behavioral therapy (CBT) (including cognitive therapy and
behavior therapy), interpersonal therapy (IPT), problem-solving
therapy (PST), mindfulness-based cognitive therapy (MBCT),
cognitive behavioral analysis system of psychotherapy (CBASP),
dialectical behavioral therapy (DBT), functional analytic
psychotherapy (FAP), acceptance and commitment therapy (ACT), or
short-term psychodynamic therapy with ≤ 8 planned sessions
Generic counseling, life review therapy,
psychoeducational therapy, supportive
therapy, bibliotherapy, or Internet-based
psychotherapies
Comparators Waitlist, attention control, usual care
Antidepressant medication if intervention is psychotherapy plus
antidepressant
Another psychotherapy
Setting Outpatient general medical or general mental health clinic Study conducted outside of North America,
Western Europe, New Zealand, or Australia




Interventions to include and exclude were selected using the Chambless et al.[REFERENCE] update on empirically validated therapies as a guide.
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